Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
Resilience has raised $825.0M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2025.
Resilience's investors include ARCH Venture Partners, Lux Capital, 8VC, New Enterprise Associates, U.S. International Development Finance Corp.
Resilience is headquartered in La Jolla, United States.
Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
Resilience is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resilience — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/resilience. Accessed September 3, 2026.
VCBacked. (2025). Resilience — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/resilience
{{cite web |title=Resilience — Funding & Investors |url=https://www.vcbacked.co/company/resilience |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated